Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HMPL-004 in mild to moderate active ulcerative colitis
NCT00659802Phase 2Completed
- Sponsor
- Hutchison MediPharma (HMP)
- Start
- Feb 2008
- Primary completion
- Oct 2009
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of andrographolide in ulcerative colitis (UC), sponsored by Hutchison MediPharma (HMP). Started Feb 2008; status: completed.
02
Drugs
andrographolide
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT00659802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00659802.